Shingrix Vaccine in Patients With Moderate to Severe Ulcerative Colitis on Tofacitinib
Clinical trial NCT03591770 · TERMINATED
Trial details
- NCT number
- NCT03591770
- Sponsor
- Boston Medical Center
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-31
- Primary completion
- 2024-07-04
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.